Scientists report success using zebrafish embryos to identify potential new diabetes drugs

In experiments with 500,000 genetically engineered zebrafish embryos, scientists report they have developed a potentially better and more accurate way to screen for useful drugs, and they have used it to identify 24 drug candidates that increase the number of insulin-producing cells in the pancreas.